Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China · Delayed Price · Currency is CNY 36.08
+1.09 (3.12%)
At close: Jul 25, 2025, 2:57 PM CST
SHE:301263 Revenue
Guangdong Taienkang Pharmaceutical had revenue of 184.66M CNY in the quarter ending March 31, 2025, a decrease of -2.35%. This brings the company's revenue in the last twelve months to 716.59M, down -5.23% year-over-year. In the year 2024, Guangdong Taienkang Pharmaceutical had annual revenue of 721.03M, down -5.23%.
Revenue (ttm)
716.59M
Revenue Growth
-5.23%
P/S Ratio
21.32
Revenue / Employee
662.89K
Employees
1,081
Market Cap
15.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 721.03M | -39.76M | -5.23% |
| Dec 31, 2023 | 760.79M | -22.69M | -2.90% |
| Jan 1, 2023 | 783.48M | 129.83M | 19.86% |
| Jan 1, 2022 | 653.65M | -55.33M | -7.80% |
| Dec 31, 2020 | 708.98M | 212.59M | 42.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |